134 related articles for article (PubMed ID: 32114288)
1. Bayesian meta-analysis of inter-phenotypic differences in human serum paraoxonase-1 activity for chemical risk assessment.
Darney K; Kasteel EEJ; Buratti FM; Turco L; Vichi S; Béchaux C; Roudot AC; Kramer NI; Testai E; Dorne JLCM; Di Consiglio E; Lautz LS
Environ Int; 2020 May; 138():105609. PubMed ID: 32114288
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase 1 status in the Thai population.
Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B
J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
4. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.
Costa LG; Giordano G; Cole TB; Marsillach J; Furlong CE
Toxicology; 2013 May; 307():115-22. PubMed ID: 22884923
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism in paraoxonase 1 (PON1): Population distribution of PON1 activity.
Ginsberg G; Neafsey P; Hattis D; Guyton KZ; Johns DO; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):473-507. PubMed ID: 20183530
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
Costa LG; Richter RJ; Li WF; Cole T; Guizzetti M; Furlong CE
Biomarkers; 2003; 8(1):1-12. PubMed ID: 12519632
[TBL] [Abstract][Full Text] [Related]
8. The role of paraoxonase polymorphisms in the induction of micronucleus in paraoxon-treated human lymphocytes.
Rojas-García AE; Sordo M; Vega L; Quintanilla-Vega B; Solis-Heredia M; Ostrosky-Wegman P
Environ Mol Mutagen; 2009 Dec; 50(9):823-9. PubMed ID: 19402156
[TBL] [Abstract][Full Text] [Related]
9. Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment.
Quignot N; Więcek W; Lautz L; Dorne JL; Amzal B
Toxicol Lett; 2021 Feb; 337():111-120. PubMed ID: 33232775
[TBL] [Abstract][Full Text] [Related]
10. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
Cole TB; Jansen K; Park S; Li WF; Furlong CE; Costa LG
Adv Exp Med Biol; 2010; 660():47-60. PubMed ID: 20221870
[TBL] [Abstract][Full Text] [Related]
11. Human variability in polymorphic CYP2D6 metabolism: Implications for the risk assessment of chemicals in food and emerging designer drugs.
Darney K; Lautz LS; Béchaux C; Wiecek W; Testai E; Amzal B; Dorne JLCM
Environ Int; 2021 Nov; 156():106760. PubMed ID: 34256299
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.
Mackness B; Durrington P; Povey A; Thomson S; Dippnall M; Mackness M; Smith T; Cherry N
Pharmacogenetics; 2003 Feb; 13(2):81-8. PubMed ID: 12563177
[TBL] [Abstract][Full Text] [Related]
13. Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1).
Searles Nielsen S; Mueller BA; De Roos AJ; Viernes HM; Farin FM; Checkoway H
Environ Health Perspect; 2005 Jul; 113(7):909-13. PubMed ID: 16002382
[TBL] [Abstract][Full Text] [Related]
14. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A
Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255
[TBL] [Abstract][Full Text] [Related]
15. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.
Costa LG; Li WF; Richter RJ; Shih DM; Lusis A; Furlong CE
Chem Biol Interact; 1999 May; 119-120():429-38. PubMed ID: 10421480
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure.
Hernández AF; Mackness B; Rodrigo L; López O; Pla A; Gil F; Durrington PN; Pena G; Parrón T; Serrano JL; Mackness MI
Hum Exp Toxicol; 2003 Nov; 22(11):565-74. PubMed ID: 14686479
[TBL] [Abstract][Full Text] [Related]
17. Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms.
Haj Mouhamed D; Ezzaher A; Mechri A; Neffati F; Omezzine A; Bouslama A; Gaha L; Douki W; Najjar MF
Environ Health Prev Med; 2012 Jul; 17(4):316-21. PubMed ID: 22205545
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms and activity of PON1 in a Mexican population.
Rojas-García AE; Solís-Heredia MJ; Piña-Guzmán B; Vega L; López-Carrillo L; Quintanilla-Vega B
Toxicol Appl Pharmacol; 2005 Jun; 205(3):282-9. PubMed ID: 15922013
[TBL] [Abstract][Full Text] [Related]
19. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
[TBL] [Abstract][Full Text] [Related]
20. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
Mutch E; Daly AK; Williams FM
Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
